Log In
Print this Print this

capmatinib (INC280) (formerly INCB28060)

  Manage Alerts
Collapse Summary General Information
Company Incyte Corp.
DescriptionOral c-Met receptor tyrosine kinase (c-MET; MET; HGFR; c-Met proto-oncogene) inhibitor
Molecular Target c-Met receptor tyrosine kinase (c-MET) (MET) (HGFR) (c-Met proto-oncogene)
Mechanism of ActionMET inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today